Business Context and Reporting Period
Oragenics, Inc. filed this Form 8-K on June 29, 2011, to report the entry into a material definitive agreement. The filing details a Third Amendment to an existing Unsecured Revolving Line of Credit with the Koski Family Limited Partnership (KFLP), the Company's largest shareholder.
Key Financial Metrics
- Credit Facility Limit: Increased from $5.0 million to $7.0 million.
- Total Borrowed to Date: $4.5 million.
- Remaining Availability: $2.5 million (including the new $2.0 million increase).
- Interest Rate: LIBOR plus 6.0%.
- Maturity Date: July 30, 2012 (extended from July 12, 2011 via the Second Amendment).
- Draw Restrictions: Future draws of the new $2.0 million are limited to $1.0 million increments, commencing no earlier than August 2011 and October 2011.
Material Changes
The primary material change is the expansion of the Company's borrowing capacity by $2.0 million. This follows a series of amendments to the original facility established in July 2010:
- Original Facility (July 2010): $2.0 million limit.
- First Amendment (Jan 2011): Increased limit to $2.5 million; Company drew an additional $500,000.
- Second Amendment (Feb 2011): Increased limit to $5.0 million; extended maturity to July 2012; added automatic conversion rights for outstanding amounts into future securities; granted KFLP a put right on undrawn amounts.
- Third Amendment (June 2011): Increased limit to $7.0 million.
Between March and June 2011, the Company borrowed an additional $2.0 million in $500,000 monthly increments for working capital and operational needs.
Outlook, Risks, and Contingencies
The filing indicates the Company is actively utilizing the credit facility for working capital and operational needs. Key terms affecting future liquidity and capital structure include:
- Conversion Rights: Outstanding amounts may automatically convert into Company securities issued in subsequent offerings.
- Put Option: KFLP retains the right to put undrawn available amounts to the Company, resulting in a note issuance.
- Related Party Transaction: The lender is the Company's largest shareholder, and the amendment was approved by the Audit Committee and disinterested directors.
The filing text does not provide specific revenue, profit, or cash flow figures for the period, nor does it contain forward-looking guidance on earnings or market conditions.
Investor Verification Checklist
- Verify the current outstanding balance of the $4.5 million borrowed and any accrued interest.
- Confirm the specific terms of the "automatic conversion" feature regarding future securities offerings.
- Review the Company's cash burn rate to assess the necessity of the full $7.0 million facility.
- Check for any subsequent filings regarding the exercise of the KFLP's put option on undrawn amounts.
- Monitor the scheduled draw dates (August and October 2011) for the new $2.0 million availability.